Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction
Article Abstract:
Prehospital thrombolytic therapy may be effective and safe for patients who are having a suspected heart attack. Thrombolytic therapy is treatment with different drugs that break up blood clots. Among 5,469 heart attack patients who had thrombolytic therapy with anistreplase, 2,750 were treated before being hospitalized and 2,719 were treated after hospitalization. Thrombolytic therapy was received an average of 55 minutes earlier by patients in the prehospital group. Eight percent of the patients who received prehospital thrombolytic therapy died from cardiac causes, compared with 10% of those who received thrombolytic therapy in the hospital. The incidence of most side effects was similar among the two groups of patients.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction
Article Abstract:
All patients who have a suspected heart attack should be given aspirin and thrombolytic drugs as soon as possible. Thrombolytic drugs break up the blood clots that cause most heart attacks. Aspirin has been shown to significantly reduce mortality rates in patients with suspected heart attack or severe angina. It also reduces the risk of a second heart attack or stroke. The anticoagulant heparin can be added to aspirin, but it can also cause bleeding. Different thrombolytic drugs seem to have similar effects except that tissue plasminogen activator (t-PA) increases the risk of stroke.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies
Article Abstract:
This article discusses a study showing that analysis of disease rates among subjects upon follow-up generally underestimates real associations of disease risk with their baseline measures. The study suggests that risk factors be remeasured at varying intervals after the initial baseline survey to avoid 'regression dilution.'
Publication Name: American Journal of Epidemiology
Subject: Health
ISSN: 0002-9262
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis. Antibody deficiency associated with gold treatment: natural history and management in 22 patients
- Abstracts: The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction
- Abstracts: A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
- Abstracts: Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Serum beta2-microglobulin in fetuses with urinary tract anomalies
- Abstracts: Getting the right employee is half the battle. Parents spell out most wanted qualities of professionals. Make an initial investment in hiring - or pay later